Form 4 for PTN PALATIN TECHNOLOGIES INC
Accepted 2025-06-17 00:00:00 ET · period of report 2025-06-13 · accession 0001654954-25-007105 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DE | 2025-06-17 | 2025-06-13 | PTN | DUNTON ALAN W | Dir | P - Purchase | $20,000.00 | +200 | 224.1K | +0.1% | — |
| D | 2025-06-17 | 2025-06-13 | PTN | DUNTON ALAN W | Dir | P - Purchase | $0.00 | +363.6K | 420.0K | +645% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Series D Preferred Stock | 2025-06-13 | P | A | 200 | $20,000.00 | 224,112 | D | — | — | (F1) Each share of Series D Convertible Preferred Stock has a stated value of $100 per share, and is convertible to common stock at an initial conversion price of $0.11 per share, for a total of 181,818 shares of common stock. The Series D Preferred Stock and Series I common stock purchase warrants were sold at a combined offering price of $0.11 per share of common stock obtainable upon conversion of the Series D Convertible Preferred Stock. |
| 2 | Derivative | Series I warrants | 2025-06-13 | P | A | 363,636 | $0.00 | 420,016 | D | $0.11 · — to — | 363,636 Common Stock | (F1) Each share of Series D Convertible Preferred Stock has a stated value of $100 per share, and is convertible to common stock at an initial conversion price of $0.11 per share, for a total of 181,818 shares of common stock. The Series D Preferred Stock and Series I common stock purchase warrants were sold at a combined offering price of $0.11 per share of common stock obtainable upon conversion of the Series D Convertible Preferred Stock. (F2) The Series I warrants are exercisable on or after the date that approval is obtained from the Issuer's stockholders as may be required by the NYSE American (or any successor entity) (the "Stockholder Approval Date"), and will expire on the five-year anniversary of the Stockholder Approval Date, subject to the terms and conditions contained in such Series I warrant. |